Capricor Therapeutics DSO Ratio | CAPR

Annual DSO Ratio Capricor Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005
-	-	-	-	-	-	31.9	44.7	47.2	20.4	14	27.5	0.136	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
47.2	0.136	26.6

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	2.94 K	-	5743.5 %	$ 69.7 M	Canada
Happiness Biotech Group Limited HAPP	29	-	1.35 %	$ 17.8 M	China
Dynavax Technologies Corporation DVAX	56.5	-	-	$ 2.02 B	USA
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	60.8	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Alpine Immune Sciences ALPN	1.73	-	-	$ 2.17 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Geron Corporation GERN	636	$ 1.42	-2.07 %	$ 947 M	USA
Affimed N.V. AFMD	31.4	-	-34.95 %	$ 21.5 M	Germany
Inhibikase Therapeutics IKT	27.9	$ 2.33	-	$ 229 M	USA
AnPac Bio-Medical Science Co., Ltd. ANPC	118	-	-1.58 %	$ 28.1 M	China
Celyad Oncology SA CYAD	64.4	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	103	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	47.6	-	-	$ 344 M	USA
IMV IMV	2.16 K	-	-	$ 13.1 M	Canada
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	3.66 K	-	-4.36 %	$ 27 M	USA
Jaguar Health JAGX	48.3	$ 0.96	-6.48 %	$ 2.24 M	USA
Johnson & Johnson JNJ	62	$ 263.4	1.58 %	$ 634 B	USA
Advaxis ADXS	3.28 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Alkermes plc ALKS	88.9	$ 52.89	-0.15 %	$ 8.71 B	Irlanda
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	126	-	-	$ 26.5 M	USA
Achieve Life Sciences ACHV	36.8	$ 6.1	-1.13 %	$ 266 M	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA